What is NDC 46708-132?

46708-132 is the product NDC for Olmesartan Medoxomil, Olmesartan medoxomil 20 mg/1 tablet, film coated, listed with the FDA by Alembic Pharmaceuticals Limited. It has 4 package NDCs, shown above in 10- and 11-digit form.

Alembic Pharmaceuticals Limited, NDC labeler code 46708. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Olmesartan Medoxomil?

122 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Olmesartan Medoxomil NDC 46708-132

NDC codes

FDA NDC Directory

Product NDC (as listed)46708-132Labeler and product segments. Claims need a package NDC.

Product NDC at billing width46708-0132Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
46708-132-10	4670801321046708013210	100 TABLET, FILM COATED in 1 CARTON (46708-132-10)Marketed from Apr 24, 2017
46708-132-30	4670801323046708013230	30 TABLET, FILM COATED in 1 BOTTLE (46708-132-30)Marketed from Apr 24, 2017
46708-132-90	4670801329046708013290	90 TABLET, FILM COATED in 1 BOTTLE (46708-132-90)Marketed from Apr 24, 2017
46708-132-91	4670801329146708013291	1000 TABLET, FILM COATED in 1 BOTTLE (46708-132-91)Marketed from Apr 24, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Olmesartan Medoxomil
Generic name (nonproprietary): olmesartan medoxomil
Active ingredients: Olmesartan medoxomil — 20 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Alembic Pharmaceuticals LimitedNDC labeler code 46708
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203012
Marketing start: Apr 24, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 46708-132_03dfb859-492b-4154-8fc7-dc4fa90cbf59SPL ID 03dfb859-492b-4154-8fc7-dc4fa90cbf59SPL set ID ac08ea7d-f529-42ca-850a-a0ecce7dc830RxCUI 349373, 349401, 349405UNII 6M97XTV3HDUPC 0346708132309, 0346708133306, 0346708131302
Pharmacologic class: Angiotensin 2 Receptor Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N446708013210 followed by a unit qualifier and the quantity

Package 46708-0132-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 18, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

1. INDICATIONS AND USAGE Olmesartan medoxomil is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with olmesartan medoxomil. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 46708-132

What is NDC 46708-132?: 46708-132 is the product NDC for Olmesartan Medoxomil, Olmesartan medoxomil 20 mg/1 tablet, film coated, listed with the FDA by Alembic Pharmaceuticals Limited. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Olmesartan Medoxomil.
What is the active ingredient?: Olmesartan medoxomil.
Who is the labeler?: Alembic Pharmaceuticals Limited, NDC labeler code 46708. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Olmesartan Medoxomil?: 122 other product NDCs are listed under this name. See all Olmesartan Medoxomil NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Olmesartan Medoxomil NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Olmesartan medoxomil	Olmesartan medoxomil 5 mg/1	TabletOral	NorthStar RxLLC	72603-950	72603-0950-0172603-0950-02
Olmesartan medoxomil	Olmesartan medoxomil 20 mg/1	TabletOral	NorthStar RxLLC	72603-951	72603-0951-0172603-0951-02
Olmesartan medoxomil	Olmesartan medoxomil 40 mg/1	TabletOral	NorthStar RxLLC	72603-952	72603-0952-0172603-0952-02
Olmesartan Medoxomil	Olmesartan medoxomil 5 mg/1	Tablet, Film coatedOral	HEC Pharm USA Inc.	72303-0848	72303-0848-0172303-0848-02
Olmesartan Medoxomil	Olmesartan medoxomil 20 mg/1	Tablet, Film coatedOral	HEC Pharm USA Inc.	72303-0849	72303-0849-0172303-0849-02
Olmesartan Medoxomil	Olmesartan medoxomil 40 mg/1	Tablet, Film coatedOral	HEC Pharm USA Inc.	72303-0850	72303-0850-0172303-0850-02
Olmesartan medoxomil	Olmesartan medoxomil 20 mg/1	TabletOral	REMEDYREPACK INC.	70518-4598	70518-4598-00
Olmesartan Medoxomil	Olmesartan medoxomil 40 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-011	60290-0011-0160290-0011-0260290-0011-03
Olmesartan Medoxomil	Olmesartan medoxomil 5 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-009	60290-0009-0160290-0009-0260290-0009-03
Olmesartan Medoxomil	Olmesartan medoxomil 20 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-010	60290-0010-0160290-0010-0260290-0010-03

All 123 Olmesartan Medoxomil NDCs

Other NDCs under ANDA 203012

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203012
Product	Strength	Form · route	Labeler	Product NDC
Olmesartan Medoxomil	Olmesartan medoxomil 5 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-131
Olmesartan Medoxomil	Olmesartan medoxomil 40 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-133
Olmesartan Medoxomil	Olmesartan medoxomil 5 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-131
Olmesartan Medoxomil	Olmesartan medoxomil 20 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-132
Olmesartan Medoxomil	Olmesartan medoxomil 40 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-133